The Murine Antitumor Immune Response and Its Therapeutic Manipulation (Q40117800)

17 September 2017

1 reference

title

The murine antitumor immune response and its therapeutic manipulation (English)

1 reference

17 September 2017

The Murine Antitumor Immune Response and Its Therapeutic Manipulation (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

author name string

R. J. North

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6235727

3 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6235727

3 September 2023

publication date

1 January 1984

1 reference

17 September 2017

Advances in Immunology

1 reference

17 September 2017

35

1 reference

17 September 2017

89-155

1 reference

Ionizing Radiation and the Immune Response

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Manipulation of host resistance in cancer therapy

3 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Bcg in Tumor Immunotherapy

3 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants

3 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

3 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity

3 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity

3 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

3 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors

3 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity

3 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes

3 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

An endotoxin-induced serum factor that causes necrosis of tumors

3 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour

3 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells

3 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice

3 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

3 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations

3 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

3 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems

3 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

33

13

835

Foley

1953

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma

3 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Abrogation of thein vitro generation of the cytotoxic T-cell response to a murine tumor: The role of suppressor cells

3 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes

3 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

3 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge

3 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon

3 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Multiple effector roles of lymphocytes in allograft immunity

3 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

43

40

4428

Greenberg

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum

3 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Regulation of Immunity to the Azobenzenearsonate Hapten

3 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cellular Immunity Against Tumor Antigens

3 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population

3 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Human tumor-associated antigens identified by monoclonal antibodies

3 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cell-Mediated Immunity to Tumor Cells

3 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Natural Cell-Mediated Immunity

3 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

A critical examination of the foundations of immunotherapy for cancer

3 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

3 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The mechanism of graft rejection and the concept of antigenic strength

3 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The T lymphocyte antigen receptor--paradigm lost

3 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Immunosuppression and the Role of Suppressive Factors in Cancer

3 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

Tumor antigens

58

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates

3 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Antigenicity of murine skin tumors induced by ultraviolet light

3 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

62

37

1395

Kripke

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection

3 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection

3 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens

3 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cancer Immunology, Immunotherapy

3 September 2023

69

2

139

Mathe

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Immunopotentiation with BCG. II. Modulation of the Response to Sheep Red Blood Cells2

3 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

3 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression

3 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

73

42

1974

Mokyr

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Contribution of host immunity to cyclophosphamide therapy of a chemically-induced murine sarcoma

3 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Suppressor Cells: Permitters and Promoters of Malignancy?

3 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

3 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites

3 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Modulation of antitumor immunity ? Immunobiologic approaches

3 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

The case history of Mr T.I. Terminal patient or still curable?

3 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

IMMUNOLOGY OF EXPERIMENTAL TUMORS.

3 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro

3 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Suppressor cell regulation of immune response to tumors: Abrogation by adult thymectomy

3 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

3 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Passive Immunotherapy of Cancer in Animals and Man

3 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response

3 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

Mechanisms of Antitumor Action of Corynebacterium parvum : Nonspecific Tumor Cell Destruction at Site of an Immunologically Mediated Sensitivity Reaction to C. parvum 2

3 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

103

Tuttle

1983

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

3 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

108

34

1532

Zbar

1974

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60575-1

3 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6235727

3 September 2023

1 reference